Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil D Perkins

Showing results (21-30 of 81) with videos related to

Pageof 9
Sort By:
Cell Cycle (Georgetown, Tex.)|June 11, 2004
Reprogramming RelAKirsteen J Campbell, Neil D Perkins
Molecular and Cellular Biology|January 2, 2003
Regulation of RelA (p65) function by the large subunit of replication factor CLisa A Anderson, Neil D Perkins
Biochemical Society Symposium|April 22, 2006
Regulation of NF-kappaB functionKirsteen J Campbell, Neil D Perkins
Biochemical Society Transactions|July 18, 2008
Regulation of the RelA (p65) transactivation domainJohn M O'Shea, Neil D Perkins
Cell Cycle (Georgetown, Tex.)|August 6, 2005
p21WAF1/CIP1 regulates the p300 sumoylation motif CRD1 through a C-terminal domain independently of cyclin/CDK bindingElisa Garcia-Wilson, Neil D Perkins
Biochemical Society Transactions|January 24, 2014
NF-κB and the cell cycleAdeline C Ledoux, Neil D Perkins
Cell Cycle (Georgetown, Tex.)|December 7, 2010
Regulation of activity and function of the p52 NF-κB subunit following DNA damageBenjamin Barré, Olivier Coqueret, Neil D Perkins
Journal of Immunology (Baltimore, Md. : 1950)|February 6, 2008
A238L inhibits NF-ATc2, NF-kappa B, and c-Jun activation through a novel mechanism involving protein kinase C-theta-mediated up-regulation of the amino-terminal transactivation domain of p300Aitor G Granja, Neil D Perkins, Yolanda Revilla
British Journal of Cancer|January 13, 2016
c-Rel and its many roles in cancer: an old story with new twistsJill E Hunter, Jack Leslie, Neil D Perkins
Molecular Cell|April 1, 2004
Active repression of antiapoptotic gene expression by RelA(p65) NF-kappa BKirsteen J Campbell, Sonia Rocha, Neil D Perkins
Pageof 9

Showing results (21-30 of 81) with videos related to

Sort By:
Pageof 9
Cell Cycle (Georgetown, Tex.)|June 11, 2004
Reprogramming RelAKirsteen J Campbell, Neil D Perkins
Molecular and Cellular Biology|January 2, 2003
Regulation of RelA (p65) function by the large subunit of replication factor CLisa A Anderson, Neil D Perkins
Biochemical Society Symposium|April 22, 2006
Regulation of NF-kappaB functionKirsteen J Campbell, Neil D Perkins
Biochemical Society Transactions|July 18, 2008
Regulation of the RelA (p65) transactivation domainJohn M O'Shea, Neil D Perkins
Cell Cycle (Georgetown, Tex.)|August 6, 2005
p21WAF1/CIP1 regulates the p300 sumoylation motif CRD1 through a C-terminal domain independently of cyclin/CDK bindingElisa Garcia-Wilson, Neil D Perkins
Biochemical Society Transactions|January 24, 2014
NF-κB and the cell cycleAdeline C Ledoux, Neil D Perkins
Cell Cycle (Georgetown, Tex.)|December 7, 2010
Regulation of activity and function of the p52 NF-κB subunit following DNA damageBenjamin Barré, Olivier Coqueret, Neil D Perkins
Journal of Immunology (Baltimore, Md. : 1950)|February 6, 2008
A238L inhibits NF-ATc2, NF-kappa B, and c-Jun activation through a novel mechanism involving protein kinase C-theta-mediated up-regulation of the amino-terminal transactivation domain of p300Aitor G Granja, Neil D Perkins, Yolanda Revilla
British Journal of Cancer|January 13, 2016
c-Rel and its many roles in cancer: an old story with new twistsJill E Hunter, Jack Leslie, Neil D Perkins
Molecular Cell|April 1, 2004
Active repression of antiapoptotic gene expression by RelA(p65) NF-kappa BKirsteen J Campbell, Sonia Rocha, Neil D Perkins
Pageof 9